Allergies News and Research

Latest Allergies News and Research

New clinical predictors required to determine future asthma attacks

Screening tests used to predict asthma activity in patients may have little tracking success when applied to people with persistent disease who are adhering to their health care regimens, UT Southwestern Medical Center physician report.

1 Sep 2009

Food guide application for iPhone/iPod users impacted by celiac/coeliac disease and food allergies

The iPhone(TM)/iPod(R) touch application, iCanEat OnTheGo Gluten & Allergen Free(TM), expands the suite of innovative solutions to help those impacted by celiac/coeliac disease, food allergies or intolerances safely eat out anywhere.

29 Aug 2009

Mylan's subsidiary notified by the WHO Prequalification of Medicines Programme

Mylan Inc. today is pleased to announce that its subsidiary Matrix Laboratories Ltd. has been notified by the World Health Organization (WHO) Prequalification of Medicines Programme that the WHO has withdrawn its notice of concern for Matrix Unit 8, which is located in the Vizianagaram District of India, with no remaining concerns outstanding.

29 Aug 2009

Express Medical Care offered by Manhattan’s Physician Group requires no appointment

Do you need to see a doctor sooner rather than later to learn if you have a simple cold vs. the flu or if that rash is an allergic reaction and not something else? Manhattan’s Physician Group now offers Express Medical Care to provide individuals with the ability to see a physician sooner rather than later.

29 Aug 2009

Enzymes could be targeted to kill dangerous pathogens

Researchers at Burnham Institute for Medical Research (Burnham), University of Texas Southwestern Medical Center and University of Maryland have demonstrated that an enzyme that is essential to many bacteria can be targeted to kill dangerous pathogens.

28 Aug 2009

Mylan Pharmaceuticals markets FDA approved first generic version of Sanofi Aventis' BenzaClin

Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has begun to market 1% Clindamycin and 5% Benzoyl Peroxide Gel based on an agreement with licensing partner Dow Pharmaceutical Sciences, a subsidiary of Valeant Pharmaceuticals International. The preparation is the first generic version of Sanofi Aventis' BenzaClin(R) to be approved by the U.S. Food and Drug Administration (FDA).

27 Aug 2009

Arrayit supplies instruments for identifying allergens

Arrayit Corporation, a proprietary life sciences technology leader, announces the sale of instruments used to identify allergens in affected individuals.

27 Aug 2009

Study reveals that asthma patients fare better by taking oral controllers than inhaled corticosteroids

Mayo Clinic Proceedings published a peer-reviewed comparative effectiveness study performed by HealthCore, Inc. in its August edition. The study demonstrated that asthma patients in general had better clinical outcomes with oral controllers than inhaled corticosteroids.

27 Aug 2009

Herbalscience research throws light on causes of allergic rhinitis

Most people might think of nettle as simply a common and aggressive weed that can sting and cause skin irritation. But nettle has also been used for hundreds of years to treat seasonal allergies and other inflammatory diseases, although the precise nature of its anti-inflammatory effect was unknown. Now, scientists with HerbalScience have identified specific bioactives in nettle leaf extracts that inhibit in vitro receptors and enzymes known to be key in generating symptoms of allergic rhinitis, or hay fever.

26 Aug 2009

New over-the-counter eye drop provides relief to seven symptoms of eye irritation

New entries in the eye care category are changing the way people can take care of their eyes.

26 Aug 2009

UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a two-year, $763,000 grant to Philip Thorpe, Ph.D., of the University of Texas Southwestern Medical Center for research expanding its studies of anti-phosphatidylserine (anti-PS) antibodies as potential treatments for viral hemorrhagic fever (VHF) infections.

26 Aug 2009

HealthCore study reports that oral controllers provide better clinical outcomes for asthma patients

Mayo Clinic Proceedings published a peer-reviewed comparative effectiveness study performed by HealthCore, Inc. in its August edition. The study demonstrated that in general had better clinical outcomes with oral controllers than inhaled corticosteroids.

26 Aug 2009

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.

26 Aug 2009

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a Phase 2 Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the development of GenVec's vector production technology.

25 Aug 2009

Damprid offers moisture absorbers that control moisture and eliminate dampness in homes

Frequent, heavy rain showers can bring needed relief from warm temperatures during the summer, however, the resulting increase in moisture and humidity makes it important to maintain a dry, healthy environment inside the home. Moisture that seeps into the home through cracks and crevices can lead to musty odors, allergens, mold and mildew that lead to or aggravate allergies, asthma and other health concerns and can even lead to structural damage.

25 Aug 2009

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, is accepting grant applications for a new initiative to establish a consortium of human immune profiling research centers.

25 Aug 2009

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

UCB and sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved XYZAL(R) (levocetirizine dihydrochloride) for children age six months and older for the relief of symptoms of perennial allergic rhinitis (indoor allergies) and chronic idiopathic urticaria (chronic hives) and for children age two years and older for symptoms of seasonal allergic rhinitis (outdoor allergies).

25 Aug 2009

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).

25 Aug 2009

Report assessing school-based policies that address the health of students released by AAFA

For over 8 million children with asthma, food allergies and related conditions, the school-house is a focal point for managing their diseases. Now for the second year in a row, the Asthma and Allergy Foundation of America (AAFA) has released a report assessing school-based policies that address student health for elementary, middle and high schools in all 50 states.

25 Aug 2009

Advisory labels to help combat swine flu

Out With Allergies LLC has announced the introduction of FluNotes(TM), "Wash Hands Fight Flu"(TM) advisory labels as a potent new weapon for combating swine flu. Available through their website, www.FluNotes.com, these stick-on notes are intended to make people more aware that they must wash their hands frequently to avoid catching and spreading the flu.

24 Aug 2009

Allergies News and Research

Latest Allergies News and Research

New clinical predictors required to determine future asthma attacks

Food guide application for iPhone/iPod users impacted by celiac/coeliac disease and food allergies

Mylan's subsidiary notified by the WHO Prequalification of Medicines Programme

Express Medical Care offered by Manhattan’s Physician Group requires no appointment

Enzymes could be targeted to kill dangerous pathogens

Mylan Pharmaceuticals markets FDA approved first generic version of Sanofi Aventis' BenzaClin

Arrayit supplies instruments for identifying allergens

Study reveals that asthma patients fare better by taking oral controllers than inhaled corticosteroids

Herbalscience research throws light on causes of allergic rhinitis

New over-the-counter eye drop provides relief to seven symptoms of eye irritation

UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies

HealthCore study reports that oral controllers provide better clinical outcomes for asthma patients

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

Damprid offers moisture absorbers that control moisture and eliminate dampness in homes

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Report assessing school-based policies that address the health of students released by AAFA

Advisory labels to help combat swine flu

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in